Make your money go further for just 25p per day

Science in Sport (AIM: SIS) - Positive financial results from this exciting sports nutrition company

26/03/2015 · Science in Sport (SIS) 

Science in Sport (SiS), a leading sports nutrition company, today announced its preliminary results. The Group has changed its year end from March to December owing to operational reasons, and as such, the results are announced as pro forma results for the 12 months to December 2014 and have been compared to the twelve months prior to this, to December 2013, to allow for a fair analysis of growth.

Sales were up across all channels with a 23.4% increase in revenue to £8.03m (2013: £6.51m) and underlying operating loss was on an improving trend in line with management expectations, at £0.19m (2013: £0.34m).

Ongoing overheads excluding sales and marketing were £1.88 million (2013: £1.38 million) for the year, reflecting a full year of costs as a standalone PLC, versus a part period in 2013 following the demerger…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Science in Sport

Episode 26 of the Investor’s Champion Podcast

13/07/2024 · Podcasts

In this episode of the Investors Champion Podcast, Chris and Lee cover a range of topics…


Fund raise | Excellent offering | Renewed focus

09/07/2024 · Company Insights

The founder’s return at a provider of vehicle tracking systems has brought renewed focus and improving…


More Company Insights

Bonkers Bargains: another great update

18/07/2024 · Alumasc Group PLC

Chain cheers | Interest winner | Meaty first

17/07/2024 · Agronomics · Gateley · Renold · Team17

Big growth in human challenge trials

17/07/2024

Sign-up to our free email updates

SIGN UP